Literature DB >> 7852582

Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers.

H S Sader1, M A Pfaller, F C Tenover, R J Hollis, R N Jones.   

Abstract

Forty-two Enterococcus faecium isolates resistant to ampicillin, penicillin, gentamicin, streptomycin, vancomycin, and teicoplanin (VanA phenotype) from 12 U.S. medical centers were analyzed by pulsed-field gel electrophoresis of chromosomal DNA. The isolates were tested for susceptibility to 12 alternative drugs. The results indicated both intrahospital and interhospital diversity among multiresistant vanA enterococcal isolates. Furthermore, the finding of isolates with identical pulsed-field gel electrophoresis patterns in different centers strongly suggests some interhospital clonal transmission.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7852582      PMCID： PMC264170          DOI： 10.1128/jcm.32.11.2840-2842.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Identification of Enterococcus species isolated from human infections by a conventional test scheme.

Authors:  R R Facklam; M D Collins
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

Review 2.  Emergence of Enterococcus as a significant pathogen.

Authors:  R C Moellering
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

Review 3.  Genetics and mechanisms of glycopeptide resistance in enterococci.

Authors:  M Arthur; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

4.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

5.  Species identification and determination of high-level aminoglycoside resistance among enterococci. Comparison study of sterile body fluid isolates, 1985-1991.

Authors:  B J Buschelman; M J Bale; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1993-02       Impact factor: 2.803

6.  Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci.

Authors:  F C Tenover; J Tokars; J Swenson; S Paul; K Spitalny; W Jarvis
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

7.  Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states.

Authors:  J W Chow; A Kuritza; D M Shlaes; M Green; D F Sahm; M J Zervos
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

8.  Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents.

Authors:  M B Huang; C N Baker; S Banerjee; F C Tenover
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

9.  Characterization of glycopeptide-resistant enterococci from U.S. hospitals.

Authors:  N C Clark; R C Cooksey; B C Hill; J M Swenson; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

10.  Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci.

Authors:  J F Boyle; S A Soumakis; A Rendo; J A Herrington; D G Gianarkis; B E Thurberg; B G Painter
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948
View more
  22 in total

1.  Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey.

Authors:  D E Perlada; A G Smulian; M T Cushion
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  From vanA Enterococcus hirae to vanA Enterococcus faecium: a study of feed supplementation with avoparcin and tylosin in young chickens.

Authors:  B Robredo; K V Singh; F Baquero; B E Murray; C Torres
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  Epidemiologic analysis of glycopeptide-resistant Enterococcus strains in neutropenic patients receiving prolonged vancomycin administration.

Authors:  P Plessis; T Lamy; P Y Donnio; F Autuly; I Grulois; P Y Le Prisé; J L Avril
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

4.  Isolation and characterization of a new bacteriocin, termed enterocin M, produced by environmental isolate Enterococcus faecium AL41.

Authors:  Mária Mareková; Andrea Lauková; Morten Skaugen; Ingolf Nes
Journal:  J Ind Microbiol Biotechnol       Date:  2007-08       Impact factor: 3.346

5.  Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci.

Authors:  Y S Chen; S A Marshall; P L Winokur; S L Coffman; W W Wilke; P R Murray; C A Spiegel; M A Pfaller; G V Doern; R N Jones
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 6.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

7.  Survey of enterococcal susceptibility patterns in Belgium.

Authors:  P Vandamme; E Vercauteren; C Lammens; N Pensart; M Ieven; B Pot; R Leclercq; H Goossens
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

8.  Apparent increased prevalence of high-level aminoglycoside-resistant Enterococcus durans resulting from false identification by a semiautomated software system.

Authors:  A Tsakris; N Woodford; S Pournaras; M Kaufmann; J Douboyas
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

Review 9.  Diversity among multidrug-resistant enterococci.

Authors:  B E Murray
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

Review 10.  Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications.

Authors:  L C McDonald; M J Kuehnert; F C Tenover; W R Jarvis
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.